290736|t|Toxic delirium after L-dopa medication.
290736|a|L-DOPA-psychosis is a frequent side effect of the combined treatment of Parkinson's disease with L-DOPA and peripherally active decarboxylase inhibitors. Regional human post-mortem brain studies showed a significant increase of noradrenaline and serotonin particularly in extrastriatal areas, whereas the lenticular nuclei were not involved. The significance of extrastriatal neurotransmitter dysfunctions for psychiatric disorders is discussed.
290736	0	14	Toxic delirium	Disease	MESH:D003693
290736	21	27	L-dopa	Chemical	MESH:D007980
290736	40	46	L-DOPA	Chemical	MESH:D007980
290736	47	56	psychosis	Disease	MESH:D011618
290736	112	131	Parkinson's disease	Disease	MESH:D010300
290736	137	143	L-DOPA	Chemical	MESH:D007980
290736	203	208	human	Species	9606
290736	268	281	noradrenaline	Chemical	MESH:D009638
290736	286	295	serotonin	Chemical	MESH:D012701
290736	416	445	neurotransmitter dysfunctions	Disease	MESH:D006331
290736	450	471	psychiatric disorders	Disease	MESH:D001523
290736	Positive_Correlation	MESH:D007980	MESH:D011618
290736	Negative_Correlation	MESH:D007980	MESH:D010300
290736	Positive_Correlation	MESH:D007980	MESH:D009638
290736	Positive_Correlation	MESH:D007980	MESH:D003693

